<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03061071</url>
  </required_header>
  <id_info>
    <org_study_id>US-2017-001</org_study_id>
    <nct_id>NCT03061071</nct_id>
  </id_info>
  <brief_title>The POSAtive Study: Study for the Treatment of Positional Obstructive Sleep Apnea</brief_title>
  <official_title>A Prospective, Randomized, Crossover Study of the NightBalance Sleep Position Trainer (SPT) Compared to Automatic Adjusting Positive Airway Pressure (APAP) for the Treatment of Positional Obstructive Sleep Apnea (POSA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NightBalance</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NightBalance</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a prospective, multi-center, randomized crossover of the NightBalance SPT
      compared to APAP for the treatment of Positional Obstructive Sleep Apnea (POSA).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a prospective, multi-center, randomized crossover of the NightBalance SPT
      compared to APAP for the treatment of POSA.

      The Primary Objective of the study is to demonstrate non-inferiority of treatment with the
      SPT as compared to APAP.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 1, 2017</start_date>
  <completion_date type="Anticipated">July 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>6 week crossover study, randomized to order of treatment</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>The technician scoring the polysomnograms will be unaware of previous PSG results from the patient to the best of their ability (ie: will not look back in their records for the purpose of reviewing their previous PSGs prior to scoring).</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Adherence (minutes of device use per night)</measure>
    <time_frame>6 week</time_frame>
    <description>Non-inferiority of SPT vs. APAP (calculated by number of minutes of objective device use per night)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Apnea-Hypopnea Index (AHI, events/hr)</measure>
    <time_frame>6 week</time_frame>
    <description>Non-inferiority of SPT vs. APAP (measured by events/hr during in lab polysomnography)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Epworth Sleepiness Scale (ESS)</measure>
    <time_frame>6 week</time_frame>
    <description>SPT vs. APAP</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional Outcomes of Sleep Questionnaire (FOSQ)</measure>
    <time_frame>6 week</time_frame>
    <description>SPT vs. APAP</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-36</measure>
    <time_frame>6 week</time_frame>
    <description>SPT vs. APAP</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction (Comfort, Satisfaction) assessed by Visual Analog Scale (VAS)</measure>
    <time_frame>6 week</time_frame>
    <description>SPT vs. APAP</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen Desaturation Index (3%)</measure>
    <time_frame>6 week</time_frame>
    <description>SPT vs. APAP</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Sleep Time (minutes)</measure>
    <time_frame>6 week</time_frame>
    <description>SPT vs. APAP (measured by in lab polysomnography)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Onset Latency (minutes)</measure>
    <time_frame>6 week</time_frame>
    <description>SPT vs. APAP (measured by in lab polysomnography)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Efficiency (%)</measure>
    <time_frame>6 week</time_frame>
    <description>SPT vs. APAP (measured by in lab polysomnography)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arousal Index</measure>
    <time_frame>6 week</time_frame>
    <description>SPT vs. APAP (measured by in lab polysomnography)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Stages (%)</measure>
    <time_frame>6 week</time_frame>
    <description>SPT vs. APAP (measured by in lab polysomnography)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Position (%)</measure>
    <time_frame>6 week</time_frame>
    <description>SPT vs. APAP (measured by in lab polysomnography)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Disease Alleviation (MDA) (%)</measure>
    <time_frame>6 weeks</time_frame>
    <description>SPT vs. APAP (MDA (%) is calculated by the product of the objective adherence (from SPT and APAP download), adjusted for total sleep time (X-axis), combined with therapeutic efficacy (AHI from the respective treatment night, Y-axis), divided by 100.)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>6 weeks</time_frame>
    <description>SPT vs. APAP, frequency, seriousness, severity and device relationship will be summarized.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Sleep Apnea Syndromes</condition>
  <arm_group>
    <arm_group_label>Randomized to SPT First: APAP Second</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Randomized to order of treatment (SPT first or APAP first) for a total of 6 weeks home use with each treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Randomized to APAP First: SPT Second</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Randomized to order of treatment (APAP first or SPT first) for a total of 6 weeks home use with each treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NightBalance Sleep Position Trainer (SPT)</intervention_name>
    <description>Subject to sleep with the SPT for a 6 week home use period followed by in-lab PSG.</description>
    <arm_group_label>Randomized to SPT First: APAP Second</arm_group_label>
    <arm_group_label>Randomized to APAP First: SPT Second</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Automated Adjusting Positive Airway Pressure (APAP)</intervention_name>
    <description>Subject to sleep with the APAP for a 6 week home use period followed by in-lab PSG.</description>
    <arm_group_label>Randomized to SPT First: APAP Second</arm_group_label>
    <arm_group_label>Randomized to APAP First: SPT Second</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject is between the ages of 20 and 80.

          2. Diagnosis of POSA meeting all the following criteria per in-lab control PSG (performed
             within 3 months of screening):

               -  Total AHI &gt;15, or AHI &gt;10 and &lt;15 with ESS &gt;10

               -  Supine AHI at least twice the non-supine AHI

               -  Non-supine AHI &lt;10 (&lt;5 in mild patients)

               -  Supine time &gt;40% and &lt;60%

          3. Subject understands the study protocol and is willing and able to comply with study
             requirements and sign informed consent.

        Exclusion Criteria:

          1. Prior surgery to treat OSA (such as UPPP), or prior or current therapy or treatment
             for OSA, with the exception of PAP being used for split night PSG only.

          2. A female of child-bearing potential that is pregnant or intends to become pregnant.

          3. Any unstable or severe medical condition of any organ system including congestive
             heart failure, COPD, renal failure, neuromuscular disease, or at the discretion of the
             site Principal Investigator (PI).

          4. Taking medication that may affect sleep, sleepiness, or alertness including hypnotics,
             sedatives, alerting agents, stimulants, opiates, sedating antidepressants, and
             anticonvulsants.

          5. Oxygen use.

          6. The presence of any other sleep disorder (central sleep apnea (CSA &gt;5), periodic limb
             movement disorder (PLMAI &gt;15), clinical diagnosis of insomnia or narcolepsy).

          7. Excessive alcohol consumption (&gt;21 drinks/week).

          8. The use of any illegal drug(s).

          9. Night or rotating shift work.

         10. Severe claustrophobia.

         11. Shoulder, neck, or back complaints that restrict sleeping position.

         12. Subject requires use of more than 2 pillows under the head while sleeping or sleeps in
             a bed/chair with raised upper body position.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard B Berry, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UF Health Sleep Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sleep Disorders Center of Alabama</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sleep Med Inc., AZ</name>
      <address>
        <city>Glendale</city>
        <state>Arizona</state>
        <zip>85306</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sleep Disorders at Magnolia Park</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kentucky Research Group</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40218</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center for Sleep and Wake Disorders</name>
      <address>
        <city>Chevy Chase</city>
        <state>Maryland</state>
        <zip>20815</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Luke's Sleep Medicine and Research Center</name>
      <address>
        <city>Chesterfield</city>
        <state>Missouri</state>
        <zip>63017</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clayton Sleep Institute</name>
      <address>
        <city>Maplewood</city>
        <state>Missouri</state>
        <zip>63143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Med One Sleep</name>
      <address>
        <city>Fayetteville</city>
        <state>North Carolina</state>
        <zip>28304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pearl Clinical Research</name>
      <address>
        <city>Paoli</city>
        <state>Pennsylvania</state>
        <zip>19301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SleepMed of South Carolina</name>
      <address>
        <city>Columbia</city>
        <state>South Carolina</state>
        <zip>29201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 13, 2017</study_first_submitted>
  <study_first_submitted_qc>February 17, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 23, 2017</study_first_posted>
  <last_update_submitted>May 21, 2018</last_update_submitted>
  <last_update_submitted_qc>May 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Positional Sleep Apnea</keyword>
  <keyword>Positional Obstructive Sleep Apnea</keyword>
  <keyword>POSA</keyword>
  <keyword>OSA</keyword>
  <keyword>Obstructive Sleep Apnea</keyword>
  <keyword>Sleep Apnea</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

